Search
Filters
Clear All
  • 5

Phase

  • 1
  • 4
  • 5
  • 4

Found 5 grafts trials

A listing of grafts medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A Prospective and Retrospective, Multi-Centre, Post-Market, Non-Interventional Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches (PANTHER)

J
Joel Corvera, MD
18-100 years
All genders
Observational
The purpose of this registry is to collect safety and performance data on all commerciallyvailable Terumo Aortic knitted and woven grafts, and cardiovascular patches in standard. Data will be collected both retrospectively and prospectively.
Learn More

Hypoesthesia Related Neurotrophic Keratitis in Patients with Ocular Graft Versus Host Disease

S
Shaohui Liu, MD
Healthy Volunteer
All genders
Hypothesize that the recalcitrant nature of ocular GVHD may be related to corneal nerve damage and corneal hypoesthesia. We aim to study the prevalence of corneal hypoesthesia in GVHD patients and its correlation with ocular surface changes. 
Learn More

Post-market real-world data collection of the Biodesign® Otologic Repair Graft.

C
Charles Yates, MD
All genders
The primary objective of this clinical study is to collect additional safety and performance data through 3-months post-operative follow-up period on the Biodesign® Otologic Repair Graft in clinical use.
Learn More

A Phase 1/2 Multi-Center Trial of Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

A
April Rahrig, MD
3-30 years
All genders
Phase 1/2
Interventional
To determine the recommended phase 2 dose (RP2D) of vorinostat in children, adolescents and young adults following allogeneic HCT. Eligibility:A prospective patient for allogeneic BMT for malignant hematologic conditions Ages 3-30 Diagnoses include:Acute Leukemia in remissionChronic Myeologenous Leukemia (CML)  Myelodysplastic syndrome (MDS) Additonal criteria must be met based on determination …
Learn More

A Pilot Study of Rituximab (RTX) and Third Party Latent Membrane Protein (LMP)-Specific Cytotoxic T-Lymphocytes in Pediatric Solid Organ Recipients (SOT) With EBV-Positive CD20-Positive Post-Transplant Lymphoproliferative Disease (PTLD)

S
Sandeep Batra, MD
All genders
This pilot clinical trial studies how rituximab and latent membrane protein (LMP)-specific T-cells work in treating pediatric solid organ recipients with Epstein-Barr virus-positive, cluster of differentiation (CD)20-positive post-transplant lymphoproliferative disorder.
Learn More